Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Canfosfamide

Generic Name: Canfosfamide

Drug Type: Small Molecule

Chemical Formula: C_₂₆H_₄₀Cl_₄N_₅O_₁₀PS

CAS Number: 158382-37-7

Unique Ingredient Identifier: 1RS284BFUI

Overview

Canfosfamide is an active agent in chemotherapy-resistant ovarian cancer.

Background

Canfosfamide is an active agent in chemotherapy-resistant ovarian cancer.

Indication

Intended for the treatment of various forms of cancer.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma

Phase 2

Completed

Posted: 2010/06/22

Sponsor:

Telik

ID:NCT01148108

Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer

Phase 3

Terminated

Posted: 2006/07/11

Sponsor:

Telik

ID:NCT00350948

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Phase 1

Completed

Posted: 2004/07/30

Sponsor:

Telik

ID:NCT00088556

TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Phase 2

Completed

Posted: 2004/01/14

Sponsor:Memorial Sloan Kette...

ID:NCT00022347

TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase 2

Completed

Posted: 2003/11/21

Sponsor:Memorial Sloan Kette...

ID:NCT00036920

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy